• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 相关卡波西肉瘤导致的慢性下肢淋巴水肿患者的蜂窝织炎。

Cellulitis in patients with chronic lower-limb lymphedema due to HIV-related Kaposi sarcoma.

机构信息

Department of Infectious Diseases, 42597Instituto Nacional de Cancerología (INCan), México.

出版信息

Int J STD AIDS. 2022 Mar;33(3):296-303. doi: 10.1177/09564624211059359. Epub 2021 Dec 30.

DOI:10.1177/09564624211059359
PMID:34965797
Abstract

OBJECTIVE

Chronic Lower Limb Lymphedema (CL-LL) secondary to Kaposi sarcoma (KS) has not been recognized as a risk factor for cellulitis. The aim was to describe the clinical spectrum and use of antimicrobial prophylaxis in patients with cellulitis and CL-LL due to KS.

METHODS

HIV patients with KS, CL-LL, and at least one episode of cellulitis seen at the AIDS Cancer Clinic at INCan in Mexico from 2004 to 2019 were included. Demographic and clinical data were obtained from medical records.

RESULTS

Thirty-nine men all with CL-LL were included. Clinical factors associated with cellulitis were groin and/or lymph-node KS infiltration (69.2%), onychomycosis and/or tinea pedis (44.7%), ulcerated lesions (38.4%), and obesity (2.5%). Eighteen (46.1%) were hospitalized in the first episode and eight (20.5%) in recurrence. Six (25.3%) died, two of toxic shock syndrome (TSS), and one of septic shock. Fourteen (35.8%) had at least one recurrent episode of cellulitis. Twenty-five (64.1%) received prophylaxis. Patients without prophylaxis had significantly more unfavorable outcomes (hospitalization and recurrences) than those with prophylaxis.

CONCLUSIONS

CL-LL due to KS is a risk factor for cellulitis and severe complications in patients with a long life expectancy. Antimicrobial prophylaxis needs to be explored as it could prevent complications.

摘要

目的

卡波西肉瘤(KS)引起的慢性下肢淋巴水肿(CL-LL)尚未被认为是蜂窝织炎的危险因素。本研究旨在描述因 KS 导致 CL-LL 并发蜂窝织炎的患者的临床特征谱和抗菌预防的使用情况。

方法

纳入 2004 年至 2019 年期间在墨西哥 INCan 的艾滋病癌症诊所就诊的患有 KS、CL-LL 且至少发生过一次蜂窝织炎的 HIV 患者。从病历中获取人口统计学和临床数据。

结果

共纳入 39 名男性患者,均患有 CL-LL。与蜂窝织炎相关的临床因素包括腹股沟和/或淋巴结 KS 浸润(69.2%)、甲真菌病和/或足癣(44.7%)、溃疡性病变(38.4%)和肥胖症(2.5%)。18 名(46.1%)患者在首次发作时住院,8 名(20.5%)在复发时住院。6 名(25.3%)患者死亡,其中 2 名死于中毒性休克综合征(TSS),1 名死于感染性休克。14 名(35.8%)至少有一次反复发作的蜂窝织炎。25 名(64.1%)患者接受了预防治疗。未接受预防治疗的患者住院和复发的不良结局明显多于接受预防治疗的患者。

结论

KS 引起的 CL-LL 是具有较长预期寿命的患者发生蜂窝织炎和严重并发症的危险因素。需要探索抗菌预防措施,因为它可以预防并发症。

相似文献

1
Cellulitis in patients with chronic lower-limb lymphedema due to HIV-related Kaposi sarcoma.HIV 相关卡波西肉瘤导致的慢性下肢淋巴水肿患者的蜂窝织炎。
Int J STD AIDS. 2022 Mar;33(3):296-303. doi: 10.1177/09564624211059359. Epub 2021 Dec 30.
2
AIDS-Related Kaposi Sarcoma Associated with Steroid-Unresponsive Periorbital Lymphedema that Responded to Chemotherapy.与类固醇无反应性眶周淋巴水肿相关的艾滋病相关性卡波西肉瘤,对化疗有反应。
Am J Case Rep. 2023 Mar 7;24:e938801. doi: 10.12659/AJCR.938801.
3
Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial.压迫疗法治疗 HIV 相关卡波西肉瘤性下肢淋巴水肿:肯尼亚简易压迫治疗卡波西肉瘤随机对照试验结果。
JCO Glob Oncol. 2022 Jan;8:e2100329. doi: 10.1200/GO.21.00329.
4
Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.卡波西肉瘤患者的临床特征、免疫重建炎症综合征的预测因素及长期预后
AIDS Res Ther. 2017 May 30;14(1):30. doi: 10.1186/s12981-017-0156-9.
5
Lymphedema and Kaposi sarcoma: A narrative review.淋巴水肿和卡波西肉瘤:一篇叙述性综述。
J Med Vasc. 2023 Nov-Dec;48(5-6):181-187. doi: 10.1016/j.jdmv.2023.10.007. Epub 2023 Nov 8.
6
Cellulitis risk factors for patients with primary or secondary lymphedema.原发性或继发性淋巴水肿患者的蜂窝织炎风险因素。
J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):179-185.e1. doi: 10.1016/j.jvsv.2021.04.009. Epub 2021 May 3.
7
Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.抗反转录病毒治疗时代卡波西肉瘤后继发癌症模式的变化。
JAMA Oncol. 2018 Jan 1;4(1):48-53. doi: 10.1001/jamaoncol.2017.2395.
8
Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.乌干达流行型卡波西肉瘤的临床表现和结局的性别差异。
PLoS One. 2010 Nov 12;5(11):e13936. doi: 10.1371/journal.pone.0013936.
9
Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.南非、马拉维和赞比亚艾滋病相关卡波西肉瘤的治疗与转归:一项国际比较
Pan Afr Med J. 2017 Nov 24;28:261. doi: 10.11604/pamj.2017.28.261.11300. eCollection 2017.
10
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.与卡波西肉瘤相关的免疫重建炎症综合征:在非洲的发病率和死亡率高于英国。
AIDS. 2013 Jun 19;27(10):1603-13. doi: 10.1097/QAD.0b013e328360a5a1.

引用本文的文献

1
Classic Kaposi Sarcoma in an Immunocompetent Male From Haiti: An Unusual Epidemiological Presentation.一名来自海地的免疫功能正常男性的经典卡波西肉瘤:一种不寻常的流行病学表现。
Cureus. 2024 Jul 14;16(7):e64518. doi: 10.7759/cureus.64518. eCollection 2024 Jul.
2
Cutaneous Kaposi Sarcoma as a Presenting Sign of HIV: A Case Report.皮肤卡波西肉瘤作为艾滋病病毒感染的首发症状:一例报告
Cureus. 2023 Dec 24;15(12):e51043. doi: 10.7759/cureus.51043. eCollection 2023 Dec.
3
Tinea pedis: an updated review.足癣:最新综述。
Drugs Context. 2023 Jun 29;12. doi: 10.7573/dic.2023-5-1. eCollection 2023.